Perkinelmer
PerkinElmer, Inc., a leading global company in the life sciences and diagnostics sectors, is headquartered in the United States. Founded in 1937, PerkinElmer has established itself as a pioneer in providing innovative solutions across various industries, including healthcare, environmental testing, and food safety. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of core products and services, such as analytical instruments, reagents, and software solutions. PerkinElmer's commitment to advancing human and environmental health is reflected in its cutting-edge technologies and comprehensive support services. Recognised for its significant contributions to the field, PerkinElmer has achieved notable milestones, including advancements in genetic testing and diagnostics. This positions the company as a trusted partner in the scientific community, dedicated to improving lives through innovation.
DitchCarbon Score
How does Perkinelmer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Perkinelmer's score of 4 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Perkinelmer's reported carbon emissions
In 2021, PerkinElmer reported total emissions of approximately 29,928,000 kg CO2e, comprising 7,579,000 kg CO2e from Scope 1 and 22,349,000 kg CO2e from Scope 2 emissions. The company has made significant strides in reducing its carbon footprint, achieving a reduction of about 1,000,000 kg CO2e in Scope 1 emissions from 2020 to 2021. Despite these reductions, PerkinElmer has not committed to net-zero emissions and currently has no specified reduction targets. The company is actively engaged in the pharmaceuticals, biotechnology, and life sciences sectors, which are increasingly under pressure to address climate change. PerkinElmer's emissions from business travel, classified under Scope 3, amounted to approximately 1,569,000 kg CO2e in 2020, indicating a need for further action in this area. The absence of long-term reduction targets highlights a potential gap in their climate strategy, which may need to be addressed to align with industry standards and stakeholder expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | |
|---|---|---|
| Scope 1 | 9,219,000 | 0,000,000 |
| Scope 2 | 27,748,000 | 00,000,000 |
| Scope 3 | 1,569,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Perkinelmer is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
